Basel, China

Sergio Rodriguez-morillas

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergio Rodriguez-morillas. Retrieved from https://idiyas.com/inventor/sergio-rodriguez-morillas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Sergio Rodriguez-Morillas

Introduction

Sergio Rodriguez-Morillas is an accomplished inventor based in Basel, Switzerland. He has made significant contributions to the field of bacteriophage research, particularly through his innovative patent.

Latest Patents

Sergio holds a patent for a composition that includes bacteriophages, α-linked polymeric glucose, and polyols. The patent, titled "Bacteriophage compositions," describes a formulation that can enhance the efficacy of bacteriophages in various applications. Notably, the α-linked polymeric glucose in his invention has a mean molecular weight of greater than 10 kDa, which is crucial for its functionality.

Career Highlights

Sergio is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work focuses on developing innovative solutions to combat bacterial infections using bacteriophage technology. His expertise and dedication have positioned him as a key player in this emerging field.

Collaborations

Sergio collaborates with notable colleagues, including Markus Rast and Tomomine Iida. Their combined efforts contribute to advancing research and development in bacteriophage applications.

Conclusion

Sergio Rodriguez-Morillas exemplifies the spirit of innovation in the pharmaceutical industry. His work on bacteriophage compositions showcases the potential of this technology in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…